Case Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure

Similar documents
I have no financial interests to disclose.

Management of Abnormal Cervical Cytology and Histology

Cervical Cancer Screening Guidelines Update

Over-diagnoses in Cytopathology: Is histology the gold standard?

I have no financial interests in any product I will discuss today.

Making Sense of Cervical Cancer Screening

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

Eradicating Mortality from Cervical Cancer

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.

Management Algorithms for Abnormal Cervical Cytology and Colposcopy

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary

Colposcopy. Attila L Major, MD, PhD

SESSION J4. What's Next? Managing Abnormal PAPs in 2014

Cervical Cancer 4/27/2016

ASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests

Managament of Abnormal Cervical Cytology and Histology

Understanding Your Pap Test Results

Your Colposcopy Visit

Clinical outcomes after conservative management of CIN1/2, CIN2, and CIN2/3 in women ages years

Samuel B. Wolf, D.O., F.A.C.O.G. Emerald Coast Obstetrics and Gynecology Panama City Florida

!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$

I have no financial interests in any product I will discuss today.

Objectives. I have no financial interests in any product I will discuss today. Cervical Cancer Screening Guidelines: Updates and Controversies

Disclosures. Learning objectives. George F. Sawaya, MD. I have nothing to disclose.

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013

I have no financial interests in any product I will discuss today.

Treatment of Cervical Intraepithelial Neoplasia. Case. How would you manage this woman?

The society for lower genital tract disorders since 1964.

Cervical Cancer Screening Update. Melissa Hartman, DO Women s Health

HPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series

No Disclosures. Updated Guidelines for Cervical Cancer Screening and Prevention Management of Abnormal Results. Objectives 5/9/2016

9/18/2008. Cervical Cancer Prevention for Adolescent Populations Garcia. Faculty disclosure. Objectives. HPV Positivity by Age (UK)

Cervical Dysplasia and HPV

Clinical Practice Guidelines June 2013

Cervical Cancer Screening. David Quinlan December 2013

Updated ASCCP Consensus Guidelines For Managing Diagnosed Cervical Cancer Precursors Michael A. Gold, M.D.

Screening for Cervical Cancer: Demystifying the Guidelines DR. NEERJA SHARMA

Cervical Conization. 1

BC Cancer Cervix Screening 2015 Program Results. February 2018

I have no financial interests in any product I will discuss today.

Becoming a colposcopist: Colposcope case studies

Understand Your Results

Update on Cervical Cancer Screening. Rahmouna Farez M.D. Assistant Professor, Medical College of Wisconsin 5/2/2014

Update on Cervical Cancer Screening

Chapter 10: Pap Test Results

Cervical Cancer Screening

SOGC / SCC Clinical Practice Guideline

What is a Pap Smear and What do the results mean? Maria E Daheri RN Cervical Nurse Case Harris Health System

Cervical Cancer Screening

X-Treme Primary Care: HPV and STIs. Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers

Cervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:

Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY

Lauren O Sullivan, D.O. February 19, 2015

Conflict of Interest Disclosure. Anita L. Nelson, MD. Principles Underlying Screening Recommendations. Learning Objectives

Cervical Screening for Dysplasia and Cancer in Patients with HIV

Lessons From Cases of Screened Women Who Developed Cervical Carcinoma

Cervical Cancer Prevention in the 21 st Century Changing Paradigms

Perfecting the Prevention of Cervical cancer. I have no financial interests in any product I will discuss today. Preview

Risk : How does it define cervical cancer screening?

What is a Pap smear?

Human Papillomavirus

Human Papillomavirus (HPV) and Cervical Cancer Prevention

Cervical Precancer: Evaluation and Management

Human Papillomavirus. Kathryn Thiessen, ARNP, ACRN The Kansas AIDS Education and Training Center The University of Kansas School of Medicine Wichita

ASCCP Guideline Changes and Management of the Abnormal Pap Test Accurately Targeting Intervention

PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT

Cuid d Fheidhmeannacht na Seirbhíse Sláinte. Part of the Health Service Executive. CS/PR/PM-20 Rev 2 ISBN Programme Report 2014/2015

Associate Professor of Gyn. & Obs., Department of Gynecology and Obstetrics, Tehran University of Medical Sciences, Iran.

BRITISH COLUMBIA S CERVICAL CANCER SCREENING PROGRAM

Screening for the Precursors of Cervical Cancer in the Era of HPV Vaccination. Dr Stella Heley Senior Liaison Physician Victorian Cytology Service

Implementation of a Research-Robust Colposcopy Management Program within the Electronic Medical Record System

Although rare, a significant increase in incidence

6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention

HPV, Cervical Dysplasia and Cancer

Details of HPV-based Cervical Cancer Screening in Turkey

WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

Colposcopy Standards Working Group 2: Risk-based colposcopy

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

Human Papillomaviruses and Cancer: Questions and Answers. Key Points. 1. What are human papillomaviruses, and how are they transmitted?

Twenty-first refresher course. Chan Kit Sheung

Jean Anderson, MD Catherine Sewell, MD, MPH

HKCOG GUIDELINES NUMBER 3 (revised November 2002) published by The Hong Kong College of Obstetricians and Gynaecologists

Streamlining Protocols-From Strategy to Implementation. Doreen Ramogola-Masire Botswana UPenn Partnership June 2014

An Update on Cervical Cancer Screening Recommendations and on the DOH BCC Program

Recommandations SSGO dépistage cancer du col utérin. Pr Patrick Petignat University Hospitals of Geneva

Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches.

CERVICAL CANCER SCREENING SCENARIOS for pan-canadian Cervical Screening Initiative

HPV infections and potential outcomes

Should Anal Pap Smears Be a Standard of Care in HIV Management?

Management that provides continuity of care for women

WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES TREATMENT FORM FORM L16

CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)

Proposed new national cervical screening program. Dr Elizabeth Jackson Obstetrician Gynaecologist Cairns

CINtec PLUS and the Pap smear: a co-testing alternative

POST-CONIZATION FOLLOW-UP OF PATIENTS WITH HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION TREATED BY LEEP PROCEDURE: A LITERATURE REVIEW

10/31/2017. Disclosures. I. Background: History 1,4. Cervical Cancer Screening and HPV

Transcription:

Disclosure Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Associate Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics This speaker has no financial interests or other relationships with industry relative to the subject of this lecture Case Based Problems Emphasis on new 2006 guidelines by ASCCP (American Society of Colposcopy and Cervical Pathology) Changes for adolescents Who needs colposcopy vs who can be managed expectantly? Next steps after colposcopy Treatment options: cryotherapy, laser, LEEP and cone biopsy Post-treatment surveillance Recommended Guidelines ASCCP guidelines For work-up of abnormal cytology: http://www.asccp.org/pdfs/consensus/algorithms_cyto_07.pdf And: AJOG 2007;197(4); 346-355. For treatment of CIN: http://www.asccp.org/pdfs/consensus/algorithms_hist_07.pdf And: AJOG 2007:197(4):340-345. SFGH 2008 guidelines in your syllabus (developed by Dr. George Sawaya, very similar to ASCCP) 1

Case 1 A 32 year old woman s s Pap smear comes back AS-CUS Case 1: ASCUS, not adolescent 3 equivalent options: 1. Repeat cytology at 6, 12 months. Colpo if >ASC 2. Immediate colpo 3. Reflex HPV test. 1. If neg rescreen in 12 months with cytology. 2. If pos cytology Case 2 An 18 year old woman just began having sexual intercourse two months prior to her visit to you for birth control pills. Her Pap smear comes back LSIL. LSIL. Case 2: LSIL in adolescent She has a follow-up pap smear in one year which also shows LSIL. What are your management options now? 2

Case 3 A 19 year old Go woman, sexually active since the age of 15, has a Pap smear read as ASC-H. H. Case 3--3 --continued Colposcopy is satisfactory and biopsy- proven CIN 2 is diagnosed in a single quadrant. Case 3: CIN 2/3 in adolescents Case 3: CIN 2/3 management options in adolescents Treatment (excision or ablation) OR observation For CIN2 observation is preferred (as long as colpo is satisfactory) if patient is reliable Colposcopy and cytology at 6 month intervals for up to 2 year Treat only if cin2 persists for >2 yrs What if her colposcopy had been unsatisfactory? ASCCP: diagnostic excisional procedure is the preferred approach 3

Case 4 A 78 year old woman who has never had any abnormal Pap smears now has a Pap smear read as ASC-US. She has not been sexually active for over 15 years. A repeat pap in 6 months is also ASC-US. Case 4: continued Colposcopy reveals an attenuated, flush cervix. Unsatisfactory. ECC shows CIN 1. Management options? Options? Case 5 A 43 year old woman has a Pap smear read as AGC (atypical glandular cells). What are your management options? Case 5 continued Colposcopy is satisfactory. ECC is normal. EMB is normal. What are your management options? 4

Case 5 continued Repeat Pap is AGC. What are your management options? Case 6 An 18 year old is referred to you with a lab report that reads ASC-US with HPV DNA test positive for a high-risk type. She undergoes colposcopy, and she is satisfactory with no lesions seen. Her repeat HPV test is still positive at one year and her colposcopy is again negative. Next steps? Case 7 A 16 year old is pregnant within six months of becoming sexually active. She was late to care at 22 weeks at which time she had a Pap smear that was read as HSIL. Case 8 A 58 year old widow has a Pap smear read as ASC-US and you send a test for HPV. It is positive. 5

Case 8 continued Colposcopy is unsatisfactory. ECC shows severe dysplasia (CIN 3) cannot rule out invasion. Case 9 A 45 year old woman has biopsy-proven proven CIN 3, a satisfactory colposcopy and a negative endocervical curettage. Case 10 A 20 year old woman has an HSIL Pap, satisfactory colposcopy and a normal endocervical curettage. General rules Less is better for adolescents (less aggressive work-up, less aggressive treatment) Don t t use HPV test in adolescents AGC is worse than ASCUS. Requires extensive work-up Typically don t t need to treat CIN1 6

Final Thoughts Make sure women have adequate education about HPV if HPV DNA testing is used Involve women in decisions when uncertainty exists in guidelines Stress smoking cessation Consider HIV testing 7